Clinical Trials Logo

Clinical Trial Summary

Dual beam Doppler Fourier-domain Optical coherence tomography (DOCT) is a noninvasive technique to quantify total retinal blood flow. To enable further development of this technique it is essential to assess short- and long-term reproducibility of DOCT blood flow measurements.


Clinical Trial Description

In the present study, total retinal blood flow will be measured with DOCT at multiple time points to gain information of short- and long-term reproducibility. In addition, provocation with flickering light will be performed, which is known to lead to vasodilatation and an increase in retinal blood flow in healthy subjects. Vessel diameters will also be measured using the Dynamic Vessel Analyzer (DVA). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03821467
Study type Interventional
Source Medical University of Vienna
Contact Doreen Schmidl, MD, PhD
Phone 0043140400
Email klin-pharmakologie@meduniwien.ac.at
Status Recruiting
Phase N/A
Start date November 19, 2018
Completion date December 12, 2023

See also
  Status Clinical Trial Phase
Completed NCT05474716 - The Effect of Topical Brimonidine on the Ocular Hemodynamics in Patients of POAG Using OCTA Phase 4
Completed NCT03068377 - The Effects of LycoRed Phytonutrient and Vitamin Supplement (a.k.a. LYC-001e) on Ocular Blood Flow N/A